Did you know there’s an injection-free way to treat high blood sugars? Inhaled insulin Afrezza is a fast-acting insulin that starts to work in minutes so you can have more freedom and spontaneity with your meal choices while still staying in control.
read more →
One of the most common challenges for people with diabetes is trying to prevent blood sugars from shooting up after meals. Drs. E and P have been managing spikes for over 75 years between the two of ’em, and they offer clear-cut suggestions on how to keep post-meal highs at bay.
read more →
The FDA recently approved a novel medication called Mounjaro. See how this once-weekly therapy works to significantly lower A1c and promote weight loss in people with type 2 diabetes.
read more →
Dr. Edelman discusses the important role ACE inhibitors and ARBs play in protecting your heart and kidneys.
read more →
Paul Reid, Founder of Type One Outdoors, leads group hikes, trail runs and other outdoor adventures for people with type 1 diabetes and their family and friends. He shares the essential supplies people with diabetes should bring on any backcountry expedition.
read more →
Some of the most beneficial medications to manage chronic diseases like diabetes are extremely expensive. UCSD pharmacist Natalie Halanski offers ideas and resources that can offer potential cost savings, including copay cards, prescription medication coupons, patient assistance foundations, extra help for Medicare, and insulin value programs.
read more →
After living with type 2 diabetes for over 25 years and recently experiencing some roller-coaster blood sugars, Ed Beberman decided to give Trulicity a try (upon his doctor’s suggestion). He shares his results and personal impressions after using the medicine for 18 months.
read more →
We are fortunate to have many medications today to treat type 2 diabetes. Beyond improving glucose levels, some of these medications also have beneficial effects on other conditions that are common in people with type 2, such as heart failure and diabetic kidney disease.
read more →
Dr. Edelman clarifies how SGLTs and GLP-1s affect insulin use, and whether or not they cause hypoglycemia.
read more →
Our international panel of diabetes experts discussed highlights from the ADA’s Scientific Sessions, and lead a Q&A on some of the most important advances in diabetes.
read more →
